Delivery Order SPE2DE21D0017-SPE2D626F00FD

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,600 delivery order by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, for COVID-19 test kits with an ultimate completion date of January 21, 2026. The contract uses a fixed-price structure with economic price adjustment provisions and includes no set-aside designation, awarded on a full and open competitive basis. Performance will occur at the contractor's facility in Lake Mary, Florida. This delivery order represents a continuation of Abbott's established role as a critical supplier of diagnostic testing supplies to federal healthcare agencies, building upon the company's extensive portfolio of contracts across the Department of Veterans Affairs, Department of Defense, and other federal entities.

Abbott Rapid DX specializes in point-of-care testing devices and rapid diagnostic solutions, with particular expertise in COVID-19 antigen testing through its BinaxNOW product line and molecular diagnostic platforms. The contractor maintains multiple indefinite delivery vehicle agreements and blanket purchase agreements with various Veterans Integrated Service Networks and federal healthcare agencies, which facilitate efficient procurement of diagnostic supplies on an as-needed basis. This modest-value delivery order is consistent with the company's typical awards ranging from approximately $600 to several thousand dollars issued through the Defense Logistics Agency Medical Supply Chain, supporting federal government medical readiness and public health initiatives.